May 2, 2017

Together, CVS and Walgreens command 90% of total US retail drug market. However, in recent days, both companies have explicitly disclosed their desire to flex muscle to outrun each other and other competitors. The major deals signed by both companies made this apparent. In this regard, could CVS for sale still be a safe channel for investors?

What’s the current market scenario?

Walgreens’ move to buy Rite Aid at a cost of approximately $17 billion emerged as a befitting reply to similar deal signed by CVS with Target’s pharmacy business for no less than $1.9 billion.

In between 2010-2015 the retail market for drug expanded by 1.3%. This makes it clear that the industry has many things to offer, from which anyone can claim a share of the profit pie. Keeping this trend intact, the market expansion will see a steep rise of 3% for the next 5 years or so. In this regard, we can presume that, no matter whoever seals the bigger deal, the profit window will remain open to companies maintaining a footprint in the industry. So, and yes, CVS for sale are still a viable option that you may look forward to, to consolidate your financial gains.

A “not so simple” model

The traditional retail narrative has felt a major tremor in the pharmacy segment. It seems like major online retailers, like Amazon, are using their leverage over a large client base to claim a possession in the sector, and to challenge the standing leaders. So, as said before, it is going to be an open to all battle. This again puts in question the feasibility of investing in CVS for sale.

CVS and Walgreens are taking it to the next level though.

Sensing this, the two major players are also stepping up their game. Selling drugs in retail is not like selling toys or other commodities. Both companies are making their pattern of service more specialized and top-notch. It is, in a way, attracting more people to get consultation from in-house pharmacists and doctor, instead of relying on online offerings completely; since drugs are nothing that you can toy away with. This places CVS for sale in a position of sheer advantage, indeed.

About the author 

Dwaine Clarke

Dwaine is the Founder and President of NNN Deal Finder an investment real estate services firm exclusively focusing on Single and Multi-Tenant Net Lease Properties. The firm provides a full range of brokerage and advisory services nationwide to High Net worth Investors, Developers, REITs and Institutional Investment Funds. Contact Dwaine to discuss securing your next investment.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Most real estate investors fail to generate predictable cash flow.

NNN Deal Finder is helping investors find stable, long-term NNN Lease investments from reputable brands with less risk and more reward.

All logos are ©Copyright, ®Registered Trademarks and courtesy of their respective companies, and are displayed in this website for the sole purpose of brand recognition in tenant labeling.

GCT Commercial Services, LLC, dba, NNN Deal Finder is a licensed real estate broker. The properties shown on this website may or may not be exclusively listed by NNN Deal Finder. All properties and information is deemed accurate and reliable but not guaranteed and should be independently verified.